Extravasation of Paclitaxel (TAXOL®) – Clinical Course

Publisher： Karger

E-ISSN： 2296-5262|22|4|318-320

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.4, 1999-09, pp. : 318-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extravasation of Oxaliplatin (Eloxatin®) – Clinical Course

By  

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 468-471

Karger

Access to resources Recommend Favorite

Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical Experience

By  

Oncology Research and Treatment, Vol. 29, Iss. 7, 2006-07 ,pp. : 314-318

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel (Taxol®) with or without Trastuzumab (Herceptin®) in Advanced Breast Cancer: A Community-Based Observation Study

By  

Oncology Research and Treatment, Vol. 26, Iss. 2, 2003-05 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

CLINICAL COURSE OF ATROPHIE BLANCHE

By  

THE JOURNAL OF DERMATOLOGY, Vol. 4, Iss. 6, 1977-12 ,pp. : 259-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 216-222

Karger

Access to resources Recommend Favorite